doi:10.3969/j.issn.1004-583X.2021.07.016

Abstract

CLC Number:

R587.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.07.016

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I7/651

References 38

[1]	江波, 邹大进, 马向华, 等. 生酮饮食干预2型糖尿病中国专家共识(2019年版)[J]. 实用临床医药杂志, 2019,23(3):1-6.
[2]	Choi YJ, Jeon SM, Shin S. Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: A meta-analysis of randomized controlled trials[J]. Nutrients, 2020,12(7):2005. doi: 10.3390/nu12072005 URL
[3]	Wilder R. The effects of ketonemia on the course of epilepsy[J]. Mayo Clin Proc, 1921,2:307-308.
[4]	Paoli A. Ketogenic diet for obesity:Friend or foe?[J]. Int J Environ Res Public Health, 2014,11(2):2092-2107. doi: 10.3390/ijerph110202092 URL
[5]	Davidson TL, Hargrave SL, Swithers SE, et al. Inter-relationships among diet, obesity and hippocampal-dependent cognitive function[J]. Neuroscience, 2013,253:110-122. doi: 10.1016/j.neuroscience.2013.08.044 pmid: 23999121
[6]	Kanikarla-Marie P, Jain SK. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes[J]. Free Radic Biol Med, 2016,95:268-277. doi: 10.1016/j.freeradbiomed.2016.03.020 URL
[7]	Chester B, Babu JR, Greene MW, et al. The effects of popular diets on type 2 diabetes management[J]. Diabetes Metab Res Rev, 2019,35(8):e3188.
[8]	Feinman RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate restriction as the first approach in diabetes management:Critical review and evidence base[J]. Nutrition, 2015,31(1):1-13. doi: 10.1016/j.nut.2014.06.011 URL
[9]	Zhang X, Qin J, Zhao Y, et al. Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice[J]. Nutr Res, 2016,36(4):349-358. doi: 10.1016/j.nutres.2015.12.002 URL
[10]	朱兵, 张晓雨, 范鸣, 等. 高脂低碳水化合物饲养加运动对2型糖尿病大鼠代谢指标的影响[J]. 中华糖尿病杂志, 2014,6(11):826-830.
[11]	Abbasi J. Interest in the ketogenic diet grows for weight loss and type 2 diabetes[J]. JAMA, 2018,319(3):215-217. doi: 10.1001/jama.2017.20639 URL
[12]	Yancy WS Jr, Mitchell NS, Westman EC. Ketogenic diet for obesity and diabetes[J]. JAMA Intern Med, 2019,179(12):1734-1735.
[13]	Gibas MK, Gibas KJ. Induced and controlled dietary ketosis as a regulator of obesity and metabolic syndrome pathologies[J]. Diabetes Metab Syndr, 2017, (Suppl 1):S385-S390.
[14]	Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study[J]. Lancet, 2017,390(10107):2050-2062. doi: 10.1016/S0140-6736(17)32252-3 URL
[15]	曹爱华, 孙丽珍, 崔静稳, 等. 低碳水化合物饮食和低脂肪饮食对2型糖尿病患者体质量及血糖的影响[J]. 中国全科医学, 2011,14(1):52-53, 56.
[16]	Ibrahim M, Tuomilehto J, Aschner P, et al. Global Status of diabetes prevention and prospects for action:A consensus statement[J]. Diabetes Metab Res Rev, 2018,34(6):e3021. doi: 10.1002/dmrr.v34.6 URL
[17]	Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition.A consensus statement from the International Diabetes Federation[J]. Diabet Med, 2006,23(5):469-480. doi: 10.1111/dme.2006.23.issue-5 URL
[18]	Bolla AM, Caretto A, Laurenzi A, et al. Low-carb and ketogenic diets in type 1 and type 2 diabetes[J]. Nutrients, 2019,11(5):962. doi: 10.3390/nu11050962 URL
[19]	Goss AM, Gower B, Soleymani T, et al. Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: A randomized clinical trial[J]. Nutr Metab (Lond), 2020,17:64. doi: 10.1186/s12986-020-00481-9 URL
[20]	Ludwig DS, Ebbeling CB. The carbohydrate-insulin model of obesity: Beyond “calories in, calories out”[J]. JAMA Intern Med, 2018,178(8):1098-1103. doi: 10.1001/jamainternmed.2018.2933 pmid: 29971406
[21]	Douris N, Desai BN, Fisher FM, et al. Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice[J]. Mol Metab, 2017,6(8):854-862. doi: 10.1016/j.molmet.2017.05.017 URL
[22]	Lyngstad A, Nymo S, Coutinho SR, et al. Investigating the effect of sex and ketosis on weight-loss-induced changes in appetite[J]. Am J Clin Nutr, 2019,109(6):1511-1518. doi: 10.1093/ajcn/nqz002 pmid: 31070711
[23]	Paoli A, Rubini A, Volek JS, et al. Beyond weight loss:A review of the therapeutic uses of very-low-carbohydrate(ketogenic) diets[J]. Eur J Clin Nutr, 2013,67(8):789-796. doi: 10.1038/ejcn.2013.116 pmid: 23801097
[24]	Veldhorst M, Smeets A, Soenen S, et al. Protein-induced satiety: Effects and mechanisms of different proteins[J]. Physiol Behav, 2008,94(2):300-307. doi: 10.1016/j.physbeh.2008.01.003 pmid: 18282589
[25]	Ebbeling CB, Feldman HA, Klein GL, et al. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: Randomized trial[J]. BMJ, 2018,363:k4583.
[26]	Cicero AF, Benelli M, Brancaleoni M, et al. Middle and long-term impact of a very low-carbohydrate ketogenic diet on cardiometabolic factors:A multi-center, cross-sectional, clinical study[J]. High Blood Press Cardiovasc Prev, 2015,22(4):389-394. doi: 10.1007/s40292-015-0096-1 URL
[27]	Gumbiner B, Wendel JA, Mcdermott MP. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus[J]. Am J Clin Nutr, 1996,63(1):110-115. pmid: 8604657
[28]	Poplawski MM, Mastaitis JW, Isoda F, et al. Reversal of diabetic nephropathy by a ketogenic diet[J]. PLoS One, 2011,6(4):e18604. doi: 10.1371/journal.pone.0018604 URL
[29]	American Diabetes Association. Standards of medical care in diabetes-2018 abridged for primary care providers[J]. Clin Diabetes, 2018,36(1):14-37. doi: 10.2337/cd17-0119 URL
[30]	Arsyad A, Idris I, Rasyid AA, et al. Long-term ketogenic diet induces metabolic acidosis, anemia, and oxidative stress in healthy wistar rats[J]. J Nutr Metab, 2020,2020:3642035.
[31]	Alarim RA, Alasmre FA, Alotaibi HA, et al. Effects of the ketogenic diet on glycemic control in diabetic patients:Meta-analysis of clinical trials[J]. Cureus, 2020,12(10):e10796.
[32]	Brouns F. Overweight and diabetes prevention: Is a low-carbohydrate-high-fat diet recommendable?[J]. Eur J Nutr, 2018,57(4):1301-1312. doi: 10.1007/s00394-018-1636-y pmid: 29541907
[33]	American Diabetes Association. Standards of medical care in diabetes-2013[J]. Diabetes Care, 2013,36(Suppl 1):S11-S66. doi: 10.2337/dc13-S011 URL
[34]	Zhang Y, Xu J, Zhang K, et al. The anticonvulsant effects of ketogenic diet on epileptic seizures and potential mechanisms[J]. Curr Neuropharmacol, 2018,16(1):66-70.
[35]	Cai QY, Zhou ZJ, Luo R, et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: A systematic review of published prospective studies[J]. World J Pediatr, 2017,13(6):528-536. doi: 10.1007/s12519-017-0053-2 URL
[36]	Rezaei S, Abdurahman AA, Saghazadeh A, et al. Short-term and long-term efficacy of classical ketogenic diet and modified atkins diet in children and adolescents with epilepsy: A systematic review and meta-analysis[J]. Nutr Neurosci, 2019,22(5):317-334. doi: 10.1080/1028415X.2017.1387721 URL
[37]	Batch JT, Lamsal SP, Adkins M, et al. Advantages and disadvantages of the ketogenic diet: A review article[J]. Cureus, 2020,12(8):e9639.
[38]	Gupta L, Khandelwal D, Kalra S, et al. Ketogenic diet in endocrine disorders:Current perspectives[J]. J Postgrad Med, 2017,63(4):242-251. doi: 10.4103/jpgm.JPGM_16_17 pmid: 29022562

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 38

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Lv Shasha, Song Jinlan, Shi Jian. Mitochondrial mutation m.3243A> G associated with diabetes mellitus: One case report and literature review [J]. Clinical Focus, 2024, 39(2): 160-163.
[2]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[3]	Liao Kunfeng, Yao Yisong, Yang Jinpan, Yang Xining, Li Yaru, Zhou Hongyan, Liang Piao. Status and influencing factors of fear of progression in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(12): 1095-1100.
[4]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[5]	Yang Xin, Xu Huajiao. Bibliometric analysis of literatures reporting psychological intervention of patients with diabetes mellitus: Based on Web of Science [J]. Clinical Focus, 2023, 38(8): 731-736.
[6]	Jin Jiahui, Yang Yang, Qin Tong, He Yuxin, Su Meihua. Probiotic supplementation on improving glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(7): 581-587.
[7]	Wu Yanan, Yan Tianmei, Liang Peng, Wei Limin. High-risk identification of depressive symptoms in middle-elderly patients with diabetes [J]. Clinical Focus, 2023, 38(6): 516-520.
[8]	Yang Minxing, Sun Lu, Ye Yun, Xu Wendong, Huang Xiaolin, Zhang Haiyun, Xu Yinglei. Characteristics of cognitive function and corresponding factors in young and middle-aged patients with type 2 diabetes with obstructive sleep apnea hypopnea syndrome [J]. Clinical Focus, 2023, 38(3): 216-220.
[9]	Rao Xiaojuan, Shi Shuangwei, Sang Yanhong. Comparison of short-term efficacy of insulin degludec/insulin versus continuous subcutaneous infusion of insulin asparton diabetic patients admitted in non-endocrinology departments [J]. Clinical Focus, 2023, 38(2): 132-136.
[10]	Xie Feifei, Zhang Weijian. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(1): 20-36.
[11]	Wang Cui, Lin Hao, Wu Pingping, Zhang Yali, Ren Jian, Xu Ting, Dong Guoyu, Zai Guotian. Correlation between hyperhomocysteinemia and early renal disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 42-45.
[12]	. [J]. Clinical Focus, 2023, 38(1): 79-83.
[13]	Wang Runqing, Wang Qian, Liao Jianxiong. A network meta-analysis of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes [J]. Clinical Focus, 2022, 37(12): 1061-1073.
[14]	Wang Wenqi, Zhang Tao. Effect of semaglutide on total myocardial ischemic burden and serum inflammatory factors in patients with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2022, 37(11): 996-1000.
[15]	. [J]. Clinical Focus, 2022, 37(10): 953-956.